Nucleic Acid Purification Systems
![Medchemexpress LLC Benzenesulfonamide, 4-[5-phenyl-3-(3-(4-(trifluoromethyl)phenyl)carbamoyl)propyl]-1H-pyrazol-1-yl | 1287761-01-6 | 98.1% | 50 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000233662.png-250.jpg)
Medchemexpress LLC Benzenesulfonamide, 4-[5-phenyl-3-(3-(4-(trifluoromethyl)phenyl)carbamoyl)propyl]-1H-pyrazol-1-yl | 1287761-01-6 | 98.1% | 50 MG
PTUPB is a research-use small molecule that potently and selectively inhibits soluble epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2). It is used in preclinical pharmacology to study inflammation and tumor biology.
- Dual sEH and COX-2 inhibition (sEH IC50 = 0.9 nM; COX-2 IC50 = 1.26 μM).
- High chemical purity (98.05% by LCMS).
- Molecular weight 543.56 g/mol; formula C26H24F3N5O3S.
- Supplied as a powder in a 50 MG pack size.
- For research use only; not for human or clinical use.
Sigma Aldrich Fine Chemicals Biosciences Guanidine hydrochloride | 50-01-1 | MFCD00013026 | 100 g
Guanidine hydrochloride | Purity: ≥99.0% | Mol Wt: 95.53 | 50-01-1 | MFCD00013026 | 100 g
Sigma Aldrich Fine Chemicals Biosciences Guanidine thiocyanate BioReagent, for molecular biology, >=99% | 593-84-0 | MFCD00013027 | 100G
Guanidine thiocyanate BioReagent, for molecular biology, >=99% | Purity: >=99% | Mol Wt: 118.16 | 593-84-0 | MFCD00013027 | 100G
Medchemexpress LLC Ptupb | 1287761-01-6 | 98.1% | 100 MG
PTUPB is a small-molecule research compound that acts as a dual inhibitor of soluble epoxide hydrolase (sEH) and cyclooxygenase-2 (COX-2), used in preclinical studies to probe combined modulation of these pathways.
- Potent dual inhibitor of sEH and COX-2 (sEH IC50 0.9 nM; COX-2 IC50 1.26 μM).
- High purity, suitable for research applications.
- Solid form with a molecular weight of 543.56 g/mol and formula C26H24F3N5O3S.
- Stable as a powder at -20°C; in solvent, long-term storage recommended at -80°C.
- Intended for research use only; not for human or diagnostic use.
Medchemexpress LLC Tedalinab | 916591-01-0 | 99.9% | 345.39 | 100 MG
Tedalinab is a potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist. It exhibits significant functional selectivity for CB2 over CB1, making it a promising compound for various therapeutic applications.
- Potent, orally active, and selective cannabinoid receptor 2 (CB2) agonist
- Exhibits greater than 4700-fold functional selectivity for CB2 over CB1
- Potential for neuropathic pain and osteoarthritis treatment
Medchemexpress LLC Tedalinab (GRC-10693) | 916591-01-0 | 99.9% | 345.39 g·mol⁻¹ | C19H21F2N3O | 10 MG
Tedalinab (GRC-10693) is a small-molecule, orally active, selective cannabinoid receptor 2 (CB2) agonist supplied as a purified research reagent for in vitro and preclinical studies. The compound is provided as a powder in milligram-scale packages and is intended for research use only (not for human or veterinary use).
- Selective CB2 receptor agonist for pharmacology studies.
- Supplied as a purified powder suitable for in vitro and preclinical work.
- Available in multiple milligram package sizes for dosing flexibility.
- High reported purity suitable for biochemical assays.
- Stable when stored under recommended conditions to preserve integrity.